Global and United States Tafenoquine Market Insights, Forecast to 2027

Report ID: 1014706 | Published Date: Oct 2024 | No. of Page: 131 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
1 Study Coverage
    1.1 Tafenoquine Product Introduction
    1.2 Market by Type
        1.2.1 Global Tafenoquine Market Size Growth Rate by Type
        1.2.2 Powder
        1.2.3 Pills
    1.3 Market by Application
        1.3.1 Global Tafenoquine Market Size Growth Rate by Application
        1.3.2 Radical Cure of P.vivax
        1.3.3 P. falciparum Treatment
        1.3.4 Prevention of Malaria Relapse
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Tafenoquine Market Size, Estimates and Forecasts
        2.1.1 Global Tafenoquine Revenue 2016-2027
        2.1.2 Global Tafenoquine Sales 2016-2027
    2.2 Global Tafenoquine, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Tafenoquine Historical Market Size by Region (2016-2021)
        2.3.1 Global Tafenoquine Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Tafenoquine Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Tafenoquine Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Tafenoquine Sales Forecast by Region (2022-2027)
        2.4.2 Global Tafenoquine Revenue Forecast by Region (2022-2027)

3 Global Tafenoquine Competitor Landscape by Players
    3.1 Global Top Tafenoquine Manufacturers by Sales
        3.1.1 Global Tafenoquine Sales by Manufacturer (2016-2021)
        3.1.2 Global Tafenoquine Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Tafenoquine Manufacturers by Revenue
        3.2.1 Key Tafenoquine Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Tafenoquine Revenue by Manufacturers (2016-2021)
        3.2.3 Global Tafenoquine Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Tafenoquine Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Tafenoquine Revenue in 2020
        3.2.6 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Tafenoquine Price by Manufacturers
    3.4 Global Tafenoquine Manufacturing Base Distribution, Product Types
        3.4.1 Tafenoquine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Tafenoquine Product Type
        3.4.3 Date of International Manufacturers Enter into Tafenoquine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Tafenoquine Market Size by Type (2016-2021)
        4.1.1 Global Tafenoquine Sales by Type (2016-2021)
        4.1.2 Global Tafenoquine Revenue by Type (2016-2021)
        4.1.3 Tafenoquine Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Tafenoquine Market Size Forecast by Type (2022-2027)
        4.2.1 Global Tafenoquine Sales Forecast by Type (2022-2027)
        4.2.2 Global Tafenoquine Revenue Forecast by Type (2022-2027)
        4.2.3 Tafenoquine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Tafenoquine Market Size by Application (2016-2021)
        5.1.1 Global Tafenoquine Sales by Application (2016-2021)
        5.1.2 Global Tafenoquine Revenue by Application (2016-2021)
        5.1.3 Tafenoquine Price by Application (2016-2021)
    5.2 Tafenoquine Market Size Forecast by Application (2022-2027)
        5.2.1 Global Tafenoquine Sales Forecast by Application (2022-2027)
        5.2.2 Global Tafenoquine Revenue Forecast by Application (2022-2027)
        5.2.3 Global Tafenoquine Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Tafenoquine Market Size YoY Growth 2016-2027
        6.1.1 United States Tafenoquine Sales YoY Growth 2016-2027
        6.1.2 United States Tafenoquine Revenue YoY Growth 2016-2027
        6.1.3 United States Tafenoquine Market Share in Global Market 2016-2027
    6.2 United States Tafenoquine Market Size by Players (International and Local Players)
        6.2.1 United States Top Tafenoquine Players by Sales (2016-2021)
        6.2.2 United States Top Tafenoquine Players by Revenue (2016-2021)
    6.3 United States Tafenoquine Historic Market Review by Type (2016-2021)
        6.3.1 United States Tafenoquine Sales Market Share by Type (2016-2021)
        6.3.2 United States Tafenoquine Revenue Market Share by Type (2016-2021)
        6.3.3 United States Tafenoquine Price by Type (2016-2021)
    6.4 United States Tafenoquine Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Tafenoquine Sales Forecast by Type (2022-2027)
        6.4.2 United States Tafenoquine Revenue Forecast by Type (2022-2027)
        6.4.3 United States Tafenoquine Price Forecast by Type (2022-2027)
    6.5 United States Tafenoquine Historic Market Review by Application (2016-2021)
        6.5.1 United States Tafenoquine Sales Market Share by Application (2016-2021)
        6.5.2 United States Tafenoquine Revenue Market Share by Application (2016-2021)
        6.5.3 United States Tafenoquine Price by Application (2016-2021)
    6.6 United States Tafenoquine Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Tafenoquine Sales Forecast by Application (2022-2027)
        6.6.2 United States Tafenoquine Revenue Forecast by Application (2022-2027)
        6.6.3 United States Tafenoquine Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Tafenoquine Market Size YoY Growth 2016-2027
    7.2 North America Tafenoquine Market Facts & Figures by Country
        7.2.1 North America Tafenoquine Sales by Country (2016-2021)
        7.2.2 North America Tafenoquine Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Tafenoquine Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Tafenoquine Market Facts & Figures by Region
        8.2.1 Asia Pacific Tafenoquine Sales by Region (2016-2021)
        8.2.2 Asia Pacific Tafenoquine Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Tafenoquine Market Size YoY Growth 2016-2027
    9.2 Europe Tafenoquine Market Facts & Figures by Country
        9.2.1 Europe Tafenoquine Sales by Country (2016-2021)
        9.2.2 Europe Tafenoquine Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Tafenoquine Market Size YoY Growth 2016-2027
    10.2 Latin America Tafenoquine Market Facts & Figures by Country
        10.2.1 Latin America Tafenoquine Sales by Country (2016-2021)
        10.2.2 Latin America Tafenoquine Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Tafenoquine Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Tafenoquine Market Facts & Figures by Country
        11.2.1 Middle East and Africa Tafenoquine Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Tafenoquine Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 GlaxoSmithKline Pharmaceuticals (GSK)
        12.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
        12.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
        12.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Products Offered
        12.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Development
    12.2 J & K Scientific LTD
        12.2.1 J & K Scientific LTD Corporation Information
        12.2.2 J & K Scientific LTD Description and Business Overview
        12.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 J & K Scientific LTD Tafenoquine Products Offered
        12.2.5 J & K Scientific LTD Recent Development
    12.3 BOC Sciences
        12.3.1 BOC Sciences Corporation Information
        12.3.2 BOC Sciences Description and Business Overview
        12.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 BOC Sciences Tafenoquine Products Offered
        12.3.5 BOC Sciences Recent Development
    12.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
        12.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
        12.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
        12.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Products Offered
        12.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development
    12.5 Pharmacodia (Beijing) Co.,Ltd
        12.5.1 Pharmacodia (Beijing) Co.,Ltd Corporation Information
        12.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
        12.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Products Offered
        12.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Development
    12.6 Amadis Chemical Company Limited
        12.6.1 Amadis Chemical Company Limited Corporation Information
        12.6.2 Amadis Chemical Company Limited Description and Business Overview
        12.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Amadis Chemical Company Limited Tafenoquine Products Offered
        12.6.5 Amadis Chemical Company Limited Recent Development
    12.7 Merck
        12.7.1 Merck Corporation Information
        12.7.2 Merck Description and Business Overview
        12.7.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Merck Tafenoquine Products Offered
        12.7.5 Merck Recent Development
    12.11 GlaxoSmithKline Pharmaceuticals (GSK)
        12.11.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
        12.11.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
        12.11.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Products Offered
        12.11.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Tafenoquine Industry Trends
    13.2 Tafenoquine Market Drivers
    13.3 Tafenoquine Market Challenges
    13.4 Tafenoquine Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Tafenoquine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Tafenoquine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Powder
    Table 3. Major Manufacturers of Pills
    Table 4. Global Tafenoquine Market Size Growth Rate by Application (2021-2027) & (Tons)
    Table 5. Global Tafenoquine Market Size by Region (Tons) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Tafenoquine Sales by Regions (2016-2021) & (Tons)
    Table 7. Global Tafenoquine Sales Market Share by Regions (2016-2021)
    Table 8. Global Tafenoquine Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Tafenoquine Sales Forecast by Region (2022-2027) & (Tons)
    Table 10. Global Tafenoquine Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Tafenoquine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Tafenoquine Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Tafenoquine Sales by Manufacturers (2016-2021) (Tons)
    Table 14. Global Tafenoquine Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Tafenoquine Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Tafenoquine Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Tafenoquine Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Tafenoquine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Tafenoquine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tafenoquine as of 2020)
    Table 20. Key Manufacturers Tafenoquine Price (2016-2021) (US$/Gram)
    Table 21. Tafenoquine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Tafenoquine Product Type
    Table 23. Date of International Manufacturers Enter into Tafenoquine Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Tafenoquine Sales by Type (2016-2021) (Tons)
    Table 26. Global Tafenoquine Sales Share by Type (2016-2021)
    Table 27. Global Tafenoquine Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Tafenoquine Revenue Share by Type (2016-2021)
    Table 29. Tafenoquine Average Selling Price (ASP) by Type (2016-2021) & (US$/Gram)
    Table 30. Global Tafenoquine Sales Forecast by Type (2022-2027) & (Tons)
    Table 31. Global Tafenoquine Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Tafenoquine Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Tafenoquine Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Tafenoquine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Gram)
    Table 35. Global Tafenoquine Sales by Application (2016-2021) (Tons)
    Table 36. Global Tafenoquine Sales Share by Application (2016-2021)
    Table 37. Global Tafenoquine Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Tafenoquine Revenue Share by Application (2016-2021)
    Table 39. Tafenoquine Average Selling Price (ASP) by Application (2016-2021) & (US$/Gram)
    Table 40. Global Tafenoquine Sales Forecast by Application (2022-2027) & (Tons)
    Table 41. Global Tafenoquine Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Tafenoquine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Tafenoquine Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Tafenoquine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Gram)
    Table 45. United States Tafenoquine Sales (Tons) of Key Companies (2016-2021)
    Table 46. United States Tafenoquine Sales Share by Company (2016-2021)
    Table 47. United States Tafenoquine Revenue (US$ Million) by Company (2016-2021)
    Table 48. United States Tafenoquine Revenue Share by Company (2016-2021)
    Table 49. United States Tafenoquine Sales (Tons) by Type (2016-2021)
    Table 50. United States Tafenoquine Sales Share by Type (2016-2021)
    Table 51. United States Tafenoquine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. United States Tafenoquine Price (US$/Gram) by Type (2016-2021)
    Table 53. United States Tafenoquine Sales (Tons) by Type (2022-2027)
    Table 54. United States Tafenoquine Sales Share by Type (2022-2027)
    Table 55. United States Tafenoquine Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. United States Tafenoquine Revenue Share by Type (2022-2027)
    Table 57. United States Tafenoquine Price (US$/Gram) by Type (2022-2027)
    Table 58. United States Tafenoquine Sales (Tons) by Application (2016-2021)
    Table 59. United States Tafenoquine Sales Share by Application (2016-2021)
    Table 60. United States Tafenoquine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. United States Tafenoquine Price (US$/Gram) by Application (2016-2021)
    Table 62. United States Tafenoquine Sales (Tons) by Application (2022-2027)
    Table 63. United States Tafenoquine Sales Share by Application (2022-2027)
    Table 64. United States Tafenoquine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. United States Tafenoquine Revenue Share by Application (2022-2027)
    Table 66. United States Tafenoquine Price (US$/Gram) by Application (2022-2027)
    Table 67. North America Tafenoquine Sales by Country (2016-2021) & (Tons)
    Table 68. North America Tafenoquine Sales Market Share by Country (2016-2021)
    Table 69. North America Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Tafenoquine Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Tafenoquine Sales by Region (2016-2021) & (Tons)
    Table 72. Asia Pacific Tafenoquine Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Tafenoquine Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Tafenoquine Revenue Market Share by Region (2016-2021)
    Table 75. Europe Tafenoquine Sales by Country (2016-2021) & (Tons)
    Table 76. Europe Tafenoquine Sales Market Share by Country (2016-2021)
    Table 77. Europe Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Tafenoquine Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Tafenoquine Sales by Country (2016-2021) & (Tons)
    Table 80. Latin America Tafenoquine Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Tafenoquine Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Tafenoquine Sales by Country (2016-2021) & (Tons)
    Table 84. Middle East and Africa Tafenoquine Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Tafenoquine Revenue Market Share by Country (2016-2021)
    Table 87. GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
    Table 88. GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
    Table 89. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 90. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product
    Table 91. GlaxoSmithKline Pharmaceuticals (GSK) Recent Development
    Table 92. J & K Scientific LTD Corporation Information
    Table 93. J & K Scientific LTD Description and Business Overview
    Table 94. J & K Scientific LTD Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 95. J & K Scientific LTD Product
    Table 96. J & K Scientific LTD Recent Development
    Table 97. BOC Sciences Corporation Information
    Table 98. BOC Sciences Description and Business Overview
    Table 99. BOC Sciences Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 100. BOC Sciences Product
    Table 101. BOC Sciences Recent Development
    Table 102. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
    Table 103. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
    Table 104. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 105. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Product
    Table 106. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development
    Table 107. Pharmacodia (Beijing) Co.,Ltd Corporation Information
    Table 108. Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
    Table 109. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 110. Pharmacodia (Beijing) Co.,Ltd Product
    Table 111. Pharmacodia (Beijing) Co.,Ltd Recent Development
    Table 112. Amadis Chemical Company Limited Corporation Information
    Table 113. Amadis Chemical Company Limited Description and Business Overview
    Table 114. Amadis Chemical Company Limited Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 115. Amadis Chemical Company Limited Product
    Table 116. Amadis Chemical Company Limited Recent Development
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Business Overview
    Table 119. Merck Tafenoquine Sales (Tons), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2016-2021)
    Table 120. Merck Product
    Table 121. Merck Recent Development
    Table 122. Tafenoquine Market Trends
    Table 123. Tafenoquine Market Drivers
    Table 124. Tafenoquine Market Challenges
    Table 125. Tafenoquine Market Restraints
    Table 126. Tafenoquine Customers List
    Table 127. Tafenoquine Distributors List
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tafenoquine Product Picture
    Figure 2. Global Tafenoquine Sales Market Share by Type in 2020 & 2027
    Figure 3. Powder Product Picture
    Figure 4. Pills Product Picture
    Figure 5. Global Tafenoquine Sales Market Share by Application in 2020 & 2027
    Figure 6. Radical Cure of P.vivax
    Figure 7. P. falciparum Treatment
    Figure 8. Prevention of Malaria Relapse
    Figure 9. Tafenoquine Report Years Considered
    Figure 10. Global Tafenoquine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Tafenoquine Market Size 2016-2027 (US$ Million)
    Figure 12. Global Tafenoquine Sales 2016-2027 (Tons)
    Figure 13. Global Tafenoquine Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Tafenoquine Sales Market Share by Region (2016-2021)
    Figure 15. Global Tafenoquine Sales Market Share by Region in 2020
    Figure 16. Global Tafenoquine Revenue Market Share by Region (2016-2021)
    Figure 17. Global Tafenoquine Revenue Market Share by Region in 2020
    Figure 18. Global Tafenoquine Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Tafenoquine Revenue in 2020
    Figure 20. Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Tafenoquine Sales Market Share by Type (2016-2021)
    Figure 22. Global Tafenoquine Sales Market Share by Type in 2020
    Figure 23. Global Tafenoquine Revenue Market Share by Type (2016-2021)
    Figure 24. Global Tafenoquine Revenue Market Share by Type in 2020
    Figure 25. Global Tafenoquine Sales Market Share by Application (2016-2021)
    Figure 26. Global Tafenoquine Sales Market Share by Application in 2020
    Figure 27. Global Tafenoquine Revenue Market Share by Application (2016-2021)
    Figure 28. Global Tafenoquine Revenue Market Share by Application in 2020
    Figure 29. United States Tafenoquine Sales Growth Rate 2016-2027 (Tons)
    Figure 30. United States Tafenoquine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. United States Tafenoquine Market Share in Global Market 2016-2027
    Figure 32. United States 5 and 10 Largest Tafenoquine Players Market Share by Revenue in Tafenoquine in 2020
    Figure 33. United States Tafenoquine Revenue Share by Type (2016-2021)
    Figure 34. United States Tafenoquine Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. United States Tafenoquine Revenue Share by Application (2016-2021)
    Figure 36. United States Tafenoquine Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Tafenoquine Sales Growth Rate 2016-2021 (Tons)
    Figure 38. North America Tafenoquine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Tafenoquine Sales Market Share by Country in 2020
    Figure 40. North America Tafenoquine Revenue Market Share by Country in 2020
    Figure 41. U.S. Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 42. U.S. Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 44. Canada Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Tafenoquine Sales Growth Rate 2016-2021 (Tons)
    Figure 46. Europe Tafenoquine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Tafenoquine Sales Market Share by Country in 2020
    Figure 48. Europe Tafenoquine Revenue Market Share by Country in 2020
    Figure 49. Germany Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 50. Germany Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 52. France Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 54. U.K. Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 56. Italy Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 58. Russia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Tafenoquine Sales Growth Rate 2016-2021 (Tons)
    Figure 60. Asia Pacific Tafenoquine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Tafenoquine Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Tafenoquine Revenue Market Share by Region in 2020
    Figure 63. China Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 64. China Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 66. Japan Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 68. South Korea Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 70. India Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 72. Australia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Taiwan Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 74. Taiwan Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 76. Indonesia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 78. Thailand Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 80. Malaysia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Philippines Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 82. Philippines Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Vietnam Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 84. Vietnam Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Latin America Tafenoquine Sales Growth Rate 2016-2021 (Tons)
    Figure 86. Latin America Tafenoquine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 87. Latin America Tafenoquine Sales Market Share by Country in 2020
    Figure 88. Latin America Tafenoquine Revenue Market Share by Country in 2020
    Figure 89. Mexico Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 90. Mexico Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Brazil Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 92. Brazil Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Argentina Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 94. Argentina Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Middle East and Africa Tafenoquine Sales Growth Rate 2016-2021 (Tons)
    Figure 96. Middle East and Africa Tafenoquine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 97. Middle East and Africa Tafenoquine Sales Market Share by Country in 2020
    Figure 98. Middle East and Africa Tafenoquine Revenue Market Share by Country in 2020
    Figure 99. Turkey Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 100. Turkey Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Saudi Arabia Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 102. Saudi Arabia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. UAE Tafenoquine Sales Growth Rate (2016-2021) (Tons)
    Figure 104. UAE Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. Tafenoquine Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Frequently Asked Questions
Tafenoquine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tafenoquine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tafenoquine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Teriflunomide

Global Teriflunomide Scope and Market Size
Teriflunomide market is segmented by com ... Read More